Professional Essentials

  • Patients Will Be Asking

Could my favorite cocktail give me more than alcohol poisoning?

  • US Professional News
  • FULLTEXT

Physician must stop marketing 3-parent baby technique

  • US Professional News
  • FULLTEXT

CMS policy spurs outpatient knee replacement

  • US Professional News
  • FULLTEXT

Adams confirmed as surgeon general

  • US Professional News
  • FULLTEXT

NPs, PAs boost productivity: survey

  • US Professional News
  • FULLTEXT

Young patients' photos lost with dermatologist's camera

View more

New in Dermatology

  • Clinical Essentials from JAMA Dermatol
  • 1 comment

Melanoma: how does age affect survival with immunotherapy?

Real-world study suggests older age may be tied to better clinical outcome.

  • Clinical Essentials from Br J Dermatol
  • 1 comment

Psoriasis: guselkumab yields good results in Japanese study

Data from a small randomized controlled trial.

  • Clinical Essentials from JAMA Dermatol
  • 1 comment
  • FULLTEXT

Dermatology: trends in malpractice claims

The highest number of claims were due to procedural errors and misdiagnoses.

  • Clinical Essentials from Dermatol Ther (Heidelb)
  • 1 comment

GPSS: a new PRO measure for genital psoriasis

A new tool for assessing treatment efficacy in clinical practice.

  • Clinical Essentials from J Dermatol
  • 1 comment

Psoriasis: secukinumab shows good long-term efficacy in Japanese study

Real-world, long-term study supports promising results from clinical trials.

  • Clinical Essentials from FDA
  • 1 comment
  • FULLTEXT

FDA approves genetic test for all solid tumor types

Assay detects all 4 classes of genomic alterations in 324 cancer-related genes.

Skin Disease Vitals for December 2017
  • Vitals
  • 1 comment

Skin Disease Vitals for December 2017

Adalimumab promising for nail psoriasis | Second-line guselkumab phase 3 results | Increased infection risk with ixekizumab in psoriasis.

  • Clinical Essentials from Br J Dermatol
  • 1 comment

Atopic dermatitis: dupilumab + topical steroids shows benefit in CsA-resistant disease

Phase 3 data from the LIBERTY AD CAFÉ trial.

  • Clinical Essentials from J Eur Acad Dermatol Venereol
  • 1 comment
  • FULLTEXT

Androgenetic alopecia: European Dermatology Forum issues new guidelines

An evidence-based tool is intended to help patient treatment.

  • Clinical Essentials from Br J Dermatol
  • 1 comment

Meta-analysis: ixekizumab tops secukinumab for psoriasis

Indirect comparison analysis suggests superiority of ixekizumab.

  • Clinical Essentials from JAMA Oncology
  • 1 comment

Cancer in the elderly: 25% of cases occur in survivors

Among younger patients, the rate is 1 in ten.

  • Clinical Essentials from Br J Dermatol
  • no comment

Psoriasis: ixekizumab increases infection risk

Integrated analysis from 7 clinical trials.

  • Clinical Essentials from JAMA Dermatol
  • 1 comment

Pediatric dermatology: parent-submitted photos >80% accurate for diagnosis

Teledermatology can improve access to care and reduce time to treatment in a cost-effective manner.

  • Clinical Essentials from J Eur Acad Dermatol Venereol
  • 1 comment

Plaque psoriasis: meta-analysis confirms tofacitinib efficacy, safety

A meta-analysis of 4 randomized controlled trials.